Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Tab To Clear Zantac Litigation Ledger Of 93% Of Complaints Pending In State Courts: $2.2Bn

Oct 10 2024

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Sanofi Eyes Using Zantac 360 Most-Recommended Ad Claim With Disclaimer Highlighting Ingredient

Nov 04 2022

Valisure Puts FDA Under Microscope In Complaint On Ranitidine Tests Seeking Damages From GSK

May 23 2024

Ranitidine Cancer Risk Found Only By Litigation Plaintiffs’ ‘Unreliable’ Research, Judge Rules

Dec 15 2022

Online Pharmacy Stirs Ranitidine Controversy With Petition To Halt Sales

Sep 15 2019

US FDA Requests Ranitidine Removal But Also Encourages Research For Stable Formulations

Apr 02 2020

GSK Agreed To Settle California Zantac Litigation After Judge Cleared Plaintiff's Experts To Testify

Jun 26 2023

Related Companies

GSK plc

Haleon plc

Sanofi

Additional Topics

United Kingdom Europe International United States Litigation OTC Drugs Safety Business Strategies Commercial Companies Compliance Consumer Drug Safety FDA Ingredients Manufacturing Policy Regulation Retail

More from United Kingdom

More from Europe

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window